These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 23041342)

  • 1. HMGB1 release by urothelial carcinoma cells is required for the in vivo antitumor response to Bacillus Calmette-Guérin.
    Zhang G; Chen F; Cao Y; Johnson B; See WA
    J Urol; 2013 Apr; 189(4):1541-6. PubMed ID: 23041342
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MB49 murine urothelial carcinoma: molecular and phenotypic comparison to human cell lines as a model of the direct tumor response to bacillus Calmette-Guerin.
    Chen F; Zhang G; Cao Y; Hessner MJ; See WA
    J Urol; 2009 Dec; 182(6):2932-7. PubMed ID: 19853870
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contributors to HMGB1 release by urothelial carcinoma cells in response to bacillus Calmette-Guérin.
    Zhang G; Chen F; Cao Y; See WA
    J Urol; 2013 Oct; 190(4):1398-403. PubMed ID: 23583857
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HMGB1 release by urothelial carcinoma cells in response to Bacillus Calmette-Guérin functions as a paracrine factor to potentiate the direct cellular effects of Bacillus Calmette-Guérin.
    Zhang G; Chen F; Cao Y; Amos JV; Shah G; See WA
    J Urol; 2013 Sep; 190(3):1076-82. PubMed ID: 23353043
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A synthetic polyvalent ligand for α5β1 integrin activates components of the urothelial carcinoma cell response to bacillus Calmette-Guérin.
    Chen F; Zhang G; Cao Y; Wakim B; See WA
    J Urol; 2013 Mar; 189(3):1104-9. PubMed ID: 22999999
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bacillus Calmette-Guerin inhibits apoptosis in human urothelial carcinoma cell lines in response to cytotoxic injury.
    Chen F; Zhang G; Cao Y; Payne R; See WA
    J Urol; 2007 Nov; 178(5):2166-70. PubMed ID: 17870116
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bacille-Calmette Guèrin induces caspase-independent cell death in urothelial carcinoma cells together with release of the necrosis-associated chemokine high molecular group box protein 1.
    See WA; Zhang G; Chen F; Cao Y; Langenstroer P; Sandlow J
    BJU Int; 2009 Jun; 103(12):1714-20. PubMed ID: 19154459
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Dose-Response Relationship of bacillus Calmette-Guérin and Urothelial Carcinoma Cell Biology.
    Shah G; Zhang G; Chen F; Cao Y; Kalyanaraman B; See WA
    J Urol; 2016 Jun; 195(6):1903-10. PubMed ID: 26694905
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fibrin clot inhibitor medication and efficacy of bacillus Calmette-Guerin for bladder urothelial cancer.
    Boorjian SA; Berglund RK; Maschino AC; Savage CJ; Herr HW
    J Urol; 2009 Oct; 182(4):1306-12. PubMed ID: 19683284
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FGFR3 Down-Regulation is Involved in bacillus Calmette-Guérin Induced Bladder Tumor Growth Inhibition.
    Langle YV; Belgorosky D; Prack McCormick B; Sahores A; Góngora A; Baldi A; Lanari C; Lamb C; Eiján AM
    J Urol; 2016 Jan; 195(1):188-97. PubMed ID: 26144336
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-interleukin-10R1 monoclonal antibody enhances bacillus Calmette-Guérin induced T-helper type 1 immune responses and antitumor immunity in a mouse orthotopic model of bladder cancer.
    Bockholt NA; Knudson MJ; Henning JR; Maymí JL; Weady P; Smith GJ; Eisenbraun MD; Fraser JD; O'Donnell MA; Luo Y
    J Urol; 2012 Jun; 187(6):2228-35. PubMed ID: 22503050
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Loss of bacillus Calmette-Guérin viability adversely affects the direct response of urothelial carcinoma cells to bacillus Calmette-Guérin exposure.
    Shah G; Zhang G; Chen F; Cao Y; Kalyanaraman B; See W
    J Urol; 2014 Mar; 191(3):823-9. PubMed ID: 24035882
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of physiological estrogen concentration on the immune response of urothelial carcinoma cells to bacillus Calmette-Guérin.
    Guise AI; Chen F; Zhang G; See W
    J Urol; 2011 Jan; 185(1):298-304. PubMed ID: 21075400
    [TBL] [Abstract][Full Text] [Related]  

  • 14. H2O2 generation by bacillus Calmette-Guérin induces the cellular oxidative stress response required for bacillus Calmette-Guérin direct effects on urothelial carcinoma biology.
    Shah G; Zielonka J; Chen F; Zhang G; Cao Y; Kalyanaraman B; See W
    J Urol; 2014 Oct; 192(4):1238-48. PubMed ID: 24928267
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Connaught and Russian strains showed the highest direct antitumor effects of different Bacillus Calmette-Guérin substrains.
    Secanella-Fandos S; Luquin M; Julián E
    J Urol; 2013 Feb; 189(2):711-8. PubMed ID: 22982433
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An analysis of the effect of statin use on the efficacy of bacillus calmette-guerin treatment for transitional cell carcinoma of the bladder.
    Berglund RK; Savage CJ; Vora KC; Kurta JM; Cronin AM
    J Urol; 2008 Oct; 180(4):1297-300; discussion 1300. PubMed ID: 18707737
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of ofloxacin on bacillus calmette-guerin induced toxicity in patients with superficial bladder cancer: results of a randomized, prospective, double-blind, placebo controlled, multicenter study.
    Colombel M; Saint F; Chopin D; Malavaud B; Nicolas L; Rischmann P
    J Urol; 2006 Sep; 176(3):935-9. PubMed ID: 16890660
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CpG therapy is superior to BCG in an orthotopic bladder cancer model and generates CD4+ T-cell immunity.
    Mangsbo SM; Ninalga C; Essand M; Loskog A; Tötterman TH
    J Immunother; 2008 Jan; 31(1):34-42. PubMed ID: 18157010
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The expression level of ligands for natural killer cell receptors predicts response to bacillus Calmette-Guerin therapy: a pilot study.
    Yutkin V; Pode D; Pikarsky E; Mandelboim O
    J Urol; 2007 Dec; 178(6):2660-4. PubMed ID: 17945285
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patterns of recurrence and outcomes following induction bacillus Calmette-Guerin for high risk Ta, T1 bladder cancer.
    Lerner SP; Tangen CM; Sucharew H; Wood D; Crawford ED
    J Urol; 2007 May; 177(5):1727-31. PubMed ID: 17437798
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.